NCT02732301

Brief Summary

The purpose of this study is to investigate the frequency and grade of gastrointestinal dysfunction in patients after thoracic cardiovascular surgery, and to search for biomarkers of gastrointestinal dysfunction. All adult patients undergoing elective cardiac surgery requiring cardiopulmonary bypass at Örebro University Hospital, Örebro, Sweden, are asked for participation in this study. All participating patients sign informed consent at the inclusion. The first three postoperative days the function of the gastrointestinal tract is scored according to a rating scale (grade 0-4), along with other clinical parameters. Plasma blood samples are collected from each patient preoperatively and the first three postoperative days. The plasma samples are stored in a biobank for later determination of plasma proteins. In the analysis, the patients are divided according to the gastrointestinal rating scale and the plasma protein expression, gastrointestinal complications and all-cause mortality are compared between the groups.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
501

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 4, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 8, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
5.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

March 10, 2021

Status Verified

March 1, 2021

Enrollment Period

1.9 years

First QC Date

April 4, 2016

Last Update Submit

March 8, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Acute gastrointestinal injury score

    Acute gastrointestinal injury score from Reintam Blaser et al (2012) modified for postoperative patients.

    Postoperative days 1-3

Secondary Outcomes (3)

  • Plasma protein expression

    Postoperative days 1-3

  • Gastrointestinal complications

    30 days postoperative

  • All cause mortality

    30 days postoperative

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients undergoing elective thoracic cardiovascular surgical procedures requiring intraoperative cardiopulmonary bypass at Örebro University Hospital, Örebro, Sweden, using a consecutive sampling method.

You may qualify if:

  • Accepted for an elective thoracic cardiovascular surgical procedure requiring cardiopulmonary bypass
  • \>18 years old

You may not qualify if:

  • Present and severe symptoms from the gastrointestinal tract
  • Previous major/extensive abdominal surgery
  • Presence of astomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Cardio-Thoracic and Vascular Surgery, Örebro University Hospital

Örebro, 70185, Sweden

Location

Related Publications (1)

  • Reintam Blaser A, Malbrain ML, Starkopf J, Fruhwald S, Jakob SM, De Waele J, Braun JP, Poeze M, Spies C. Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems. Intensive Care Med. 2012 Mar;38(3):384-94. doi: 10.1007/s00134-011-2459-y. Epub 2012 Feb 7.

    PMID: 22310869BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Four plasma samples, 2 ml each, taken preoperatively and the three first postoperative days, which are stored in an approved biobank.

Study Officials

  • Kristofer F Nilsson, MD, PhD

    Department of Cardio-Thoracic and Vascular Surgery, Örebro University Hospital, Örebro, SWEDEN

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 4, 2016

First Posted

April 8, 2016

Study Start

November 1, 2015

Primary Completion

October 1, 2017

Study Completion

December 1, 2022

Last Updated

March 10, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations